1. Home
  2. OLMA vs FAX Comparison

OLMA vs FAX Comparison

Compare OLMA & FAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • FAX
  • Stock Information
  • Founded
  • OLMA 2006
  • FAX 1986
  • Country
  • OLMA United States
  • FAX United States
  • Employees
  • OLMA N/A
  • FAX N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • FAX Investment Managers
  • Sector
  • OLMA Health Care
  • FAX Finance
  • Exchange
  • OLMA Nasdaq
  • FAX Nasdaq
  • Market Cap
  • OLMA 560.7M
  • FAX 672.5M
  • IPO Year
  • OLMA 2020
  • FAX N/A
  • Fundamental
  • Price
  • OLMA $10.48
  • FAX $15.80
  • Analyst Decision
  • OLMA Strong Buy
  • FAX
  • Analyst Count
  • OLMA 5
  • FAX 0
  • Target Price
  • OLMA $24.00
  • FAX N/A
  • AVG Volume (30 Days)
  • OLMA 1.2M
  • FAX 833.6K
  • Earning Date
  • OLMA 11-11-2025
  • FAX 01-01-0001
  • Dividend Yield
  • OLMA N/A
  • FAX 12.09%
  • EPS Growth
  • OLMA N/A
  • FAX N/A
  • EPS
  • OLMA N/A
  • FAX N/A
  • Revenue
  • OLMA N/A
  • FAX N/A
  • Revenue This Year
  • OLMA N/A
  • FAX N/A
  • Revenue Next Year
  • OLMA N/A
  • FAX N/A
  • P/E Ratio
  • OLMA N/A
  • FAX N/A
  • Revenue Growth
  • OLMA N/A
  • FAX N/A
  • 52 Week Low
  • OLMA $2.86
  • FAX $2.33
  • 52 Week High
  • OLMA $13.51
  • FAX $2.84
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 70.04
  • FAX 32.15
  • Support Level
  • OLMA $8.01
  • FAX $15.70
  • Resistance Level
  • OLMA $11.54
  • FAX $16.68
  • Average True Range (ATR)
  • OLMA 0.79
  • FAX 0.23
  • MACD
  • OLMA 0.14
  • FAX -0.09
  • Stochastic Oscillator
  • OLMA 72.61
  • FAX 8.70

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About FAX abrdn Asia-Pacific Income Fund Inc.

Aberdeen Asia-pacific Income Fund Inc is a United States-based closed-end, non-diversified management investment company. Its principal investment objective is to seek current income along with capital appreciation. The fund invests in Asian debt securities, Australian debt securities, European debt securities and others.

Share on Social Networks: